Quest Diagnostics Inc (DGX)
125.91
-1.07
(-0.84%)
USD |
NYSE |
Apr 18, 16:00
125.94
+0.03
(+0.02%)
Pre-Market: 20:00
Quest Diagnostics Cash from Investing (Quarterly): -114.00M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -114.00M |
September 30, 2023 | -107.00M |
June 30, 2023 | -682.00M |
March 31, 2023 | -158.00M |
December 31, 2022 | -174.00M |
September 30, 2022 | -118.00M |
June 30, 2022 | -82.00M |
March 31, 2022 | -169.00M |
December 31, 2021 | -227.00M |
September 30, 2021 | -96.00M |
June 30, 2021 | 437.00M |
March 31, 2021 | -93.00M |
December 31, 2020 | -168.00M |
September 30, 2020 | -193.00M |
June 30, 2020 | -205.00M |
March 31, 2020 | -206.00M |
December 31, 2019 | -100.00M |
September 30, 2019 | -109.00M |
June 30, 2019 | -92.00M |
March 31, 2019 | -110.00M |
December 31, 2018 | -346.00M |
September 30, 2018 | -125.00M |
June 30, 2018 | -126.00M |
March 31, 2018 | -204.00M |
December 31, 2017 | -366.00M |
Date | Value |
---|---|
September 30, 2017 | -247.00M |
June 30, 2017 | -170.00M |
March 31, 2017 | -47.00M |
December 31, 2016 | -82.00M |
September 30, 2016 | -72.00M |
June 30, 2016 | 217.00M |
March 31, 2016 | -190.00M |
December 31, 2015 | -125.00M |
September 30, 2015 | -114.00M |
June 30, 2015 | -68.00M |
March 31, 2015 | -55.00M |
December 31, 2014 | -91.00M |
September 30, 2014 | -93.00M |
June 30, 2014 | -205.00M |
March 31, 2014 | -636.00M |
December 31, 2013 | -105.00M |
September 30, 2013 | 452.00M |
June 30, 2013 | 121.00M |
March 31, 2013 | -140.00M |
December 31, 2012 | -42.01M |
September 30, 2012 | -44.45M |
June 30, 2012 | -47.30M |
March 31, 2012 | -83.24M |
December 31, 2011 | -40.94M |
September 30, 2011 | -194.09M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-682.00M
Minimum
Jun 2023
437.00M
Maximum
Jun 2021
-139.79M
Average
-118.00M
Median
Sep 2022
Cash from Investing (Quarterly) Benchmarks
Laboratory Corp of America Holdings | -330.60M |
Exact Sciences Corp | -66.77M |
Illumina Inc | -85.00M |
Natera Inc | 24.66M |
Progyny Inc | -93.41M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | 527.00M |
Cash from Financing (Quarterly) | 130.00M |
Free Cash Flow | 864.00M |
Free Cash Flow Per Share (Quarterly) | 4.062 |
Free Cash Flow to Equity (Quarterly) | -137.00M |
Free Cash Flow to Firm (Quarterly) | 488.25M |
Free Cash Flow Yield | 6.06% |